AngioDynamics Provides Updates on Vascular Access Businesses

Register to receive a free Vascular Access Devices and Accessories Market Report Suite for US 2018-2024 synopsis and brochure

AngioDynamics, Inc., a leading provider of innovative, minimally invasive medical devices for vascular access, peripheral vascular disease and oncology, acknowledged a recent, favorable U.S. District Court ruling that impacts its Vascular Access business.

In May of 2017, AngioDynamics filed a lawsuit against C.R. Bard (Bard) for violating United States antitrust laws with its practice of illegally tying tip location system sales to its line of peripherally inserted central catheters (PICCs). On Monday, August 6, the U.S. District Court for the Northern District of New York rejected – in its entirety – C.R. Bard’s motion to dismiss AngioDynamics’ lawsuit against it.

As a result of last week’s ruling, AngioDynamics’ antitrust lawsuit against Bard will proceed.

Tip location systems are devices that can be used to aid healthcare professionals in the bed-side placement of a PICC. The lawsuit claims that Bard has a dominant position in the tip location system market and will only sell the proprietary stylet necessary to operate its tip location systems preloaded in its PICCs, not separately, which would allow any type of PICC to be used with the tip location systems. By doing so, customers who want to buy Bard’s tip location systems must also buy Bard’s line of PICCs, which prevents hospitals and other medical providers from purchasing BioFlo PICCs from AngioDynamics’ Vascular Access business.

AngioDynamics’ lawsuit seeks to end Bard’s violation of the antitrust laws and to recover treble damages for losses due to Bard’s violations, as well as attorneys’ fees and other costs. AngioDynamics is represented by Philip Iovieno and Anne Nardacci of the law firm of Boies Schiller Flexner LLP.

About AngioDynamics

AngioDynamics, Inc. is a leading provider of innovative, minimally invasive medical devices used by professional healthcare providers for vascular access, peripheral vascular disease and oncology. AngioDynamics’ diverse product lines include market-leading ablation systems, fluid management systems, vascular access products, angiographic products and accessories drainage products, thrombolytic products and venous products.


For Further Information

More on the vascular access device market in the U.S. can be found in a series of reports published by iData Research, entitled the U.S. Market Report Suite for Vascular Access Devices and Accessories 2018. The U.S. market for vascular access devices and accessories includes implantable ports, port needles, central venous catheters (CVCs), peripherally inserted central catheters (PICCs), peripheral intravenous catheters (PIVCs), midlines, dialysis catheters, ultrasound systems, tip guidance devices, catheter securement devices, syringes, and needles.

The iData report series on vascular access devices covers the U.S., Brazil, South Korea, Japan, Australia, China, India, and 15 countries in Europe including Germany, France, the United Kingdom (U.K.), Italy, Spain, Benelux (Belgium, Netherlands, and Luxembourg), Scandinavia (Finland, Denmark, Sweden, and Norway), Portugal, Austria, and Switzerland. Reports provide a comprehensive analysis including units sold, market value, forecasts, as well as detailed competitive market shares and analysis of major players’ success strategies in each market and segment. To find out more about vascular access device market data, register online or email us at for the U.S. Market Report Suite for Vascular Access Devices and Accessories 2018 brochure and synopsis.

Leave a Reply